Modex’s EBV vaccine given to first participant in Phase 1 trial
A Phase 1 clinical trial that is investigating a new vaccine against the Epstein-Barr virus (EBV), a well-established risk…
Articles by Esteban Domínguez Cerezo, MS
Vascular age seen higher than chronological age in MS patients
People with multiple sclerosis (MS) show significant differences between actual age and vascular age, an indicator of heart and…
Steady rise in MS seen among adults older than age 50 in Italy
The incidence of late-onset multiple sclerosis (LOMS), a form of multiple sclerosis (MS) that begins after age 50, has…
Phase 2 trial testing foralumab in nonactive SPMS adds 6 US sites
Tiziana Life Sciences is expanding its Phase 2 clinical trial testing foralumab nasal spray for the treatment of nonactive…
Dosing begins in early clinical trial of Lucid-MS to protect myelin sheath
A first group of healthy adults has been dosed in a Phase 1 safety and tolerability trial of Lucid-21-302, a…
Nerve stimulator for myelin repair to enter RRMS clinical trial
SetPoint Medical is planning to launch a clinical trial next year to investigate its nerve stimulator device, intending…
Plasma exchange therapy found effective for severe MS relapses
Plasma exchange (PLEX) therapy is effective for severe relapses in people with multiple sclerosis (MS) who respond inadequately…
Rubella infection may increase MS risk in unvaccinated people
Having antibodies against the rubella virus is associated with an increased risk of developing multiple sclerosis (MS) in unvaccinated…
EU patent given to arsenic trioxide, aiming to treat RRMS
A potential treatment of relapsing-remitting multiple sclerosis (RRMS), arsenic trioxide (ATO) has been patented in the European Union based…
NIH grant supports PhD student’s study into fear of falling with MS
A grant from the National Institutes of Health (NIH) is supporting a U.S. study into the physical, cognitive, and psychological…
Phase 1 trial to begin of CAR T-cell therapy azer-cel for progressive MS
TG Therapeutics plans to soon launch a Phase 1 clinical trial to investigate the CAR T-cell therapy…
Indapta plans trial of cell-based therapy IDP-023 in progressive MS
Indapta Therapeutics will launch a Phase 1 clinical trial in the U.S. in the second half of 2024 to…
Acthar Gel self-injection option available in US, Mallinckrodt says
People with multiple sclerosis (MS) and other conditions who use Mallinckrodt‘s treatment Acthar Gel (repository corticotropin injection)…
MS Australia funds 3 innovative MS projects to address unmet needs
Three innovative projects aimed at addressing unmet needs in multiple sclerosis (MS) and fostering new perspectives on the disease…